🇦🇪 Sunlenca in United Arab Emirates

Sunlenca (LENACAPAVIR) regulatory status in United Arab Emirates.

Marketing authorisations

MOH

  • Status: likely_approved

MOH

  • Status: likely_approved

MOH

  • Status: likely_approved

MOH

  • Status: likely_approved

Sunlenca in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Infectious Disease approved in United Arab Emirates

Frequently asked questions

Is Sunlenca approved in United Arab Emirates?

Yes. MOH has authorised it; MOH has authorised it; MOH has authorised it.

Who is the marketing authorisation holder for Sunlenca in United Arab Emirates?

Gilead Sciences is the originator. The local marketing authorisation holder may differ — check the official source linked above.